Brandywine, MD, United States of America

Berthel Floyne Tate


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Berthel Floyne Tate: Innovator in Telehealth Communications

Introduction

Berthel Floyne Tate is an accomplished inventor based in Brandywine, MD (US). He has made significant contributions to the field of telehealth communications, focusing on enhancing patient-centeredness through innovative technologies. His work is particularly relevant in today's digital age, where telehealth has become increasingly important.

Latest Patents

Berthel holds a patent for a teleconferencing system designed to support patient-centeredness in telehealth communications. This system includes a dominance calculator, which computes a dominance score for various communication channels based on received video and audio. Additionally, the system features a view engine that sends a display overlay with a visual indicator of the computed dominance score to the relevant communication channel. This innovation aims to improve the quality and effectiveness of telehealth interactions.

Career Highlights

Berthel is currently employed at Koninklijke Philips Corporation N.V., a leading company in health technology. His role involves developing advanced telehealth solutions that cater to the needs of patients and healthcare providers alike. With a focus on user experience, Berthel's work is instrumental in shaping the future of telehealth.

Collaborations

Berthel collaborates with Matthew Len Lee, a fellow innovator in the field. Together, they work on projects that aim to enhance telehealth systems and improve patient engagement through technology.

Conclusion

Berthel Floyne Tate is a notable inventor whose work in telehealth communications is paving the way for more effective patient-centered care. His innovative patent and collaboration with industry professionals highlight his commitment to improving healthcare through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…